Superlative Biosciences Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Superlative Biosciences

Access the complete profile.

Superlative Biosciences Fast Facts

Revenue	N/A    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	325413 In-Vitro Diagnostic Substance Manufacturing
Additional NAICS Codes	325414 Biological Product Manufacturing 541711 Research & Development in Biotechnology
Address	4734 Sabre Lane Manlius, NY 13104

Note: Revenues for privately held companies are statistical evaluations.


Superlative Biosciences's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Superlative Biosciences's annual revenues are N/A (see exact revenue data)
• What industry is the company in?
  • Superlative Biosciences is classified as operating in the In-Vitro Diagnostic Substance Manufacturing industry, NAICS Code 325413.

Market Share of Superlative Biosciences's Largest Competitors

A competitive analysis shows these companies are in the same general field as Superlative Biosciences, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
CUE HEALTH	San Diego, CA	100
ACCESS BIO	Somerset, NJ	24
AALTO SCIENTIFIC	Eatonton, GA	17
LUMINOSTICS	Fremont, CA	7
SDIX	Newark, DE	4
SEDIA BIOSCIENCES	Beaverton, OR	3
ZEPTO LIFE TECHNOLOGY	Saint Paul, MN	3
ARLINGTON SCIENTIFIC	Springville, UT	2
BIOPOOL US	Jamestown, NY	2

Future Competition: Superlative Biosciences's Fastest Growing Competitors

These companies are in the same general field as Superlative Biosciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)